Final results of the HERACLES trial in HER2-amplified colorectal cancer

Treatment choices for HER2 amplified colorectal cancer

Results of SUMMIT: a global phII trial of neratinib in HER2/3 mutant solid tumours

Neratinib in HER2 or HER3 mutant solid tumours

Understanding response and resistance to cancer therapy: Lessons learned from melanoma

Tumour-treating fields complement chemotherapy in aggressive brain tumours

Tumour treating fields added to standard chemotherapy in newly diagnosed glioblastoma (GBM):

The work of CanSupport

Cervical cancer reduction with HPV vaccines

75 years of Tata Memorial Centre

Surgery over SBRT for early lung cancer

SBRT or surgery for early lung cancer?